Lung cancer in never smokers: A French national cohort (BioCAST/IFCT-1002);BioCAST: le Bio-observatoire national du cancer bronchiques chez les patients non fumeurs (IFCT1002)

Revue des Maladies Respiratoires

Volumn 30, Issue 7, 2013, Pages 576-583

  Couraud, S ^a,b,c   Labonne, S ^a,b,c   Missy, P ^c   Morin, F ^c   Tran, Q ^c   Deroy, A ^c   Milleron, B ^c   Blanche H ^e   Zalcman, G ^c,d   Souquet, P J ^a,b,c  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Intergroupe Francophone de Cancérologie Thoracique Paris   (France)

^d CAEN UNIVERSITY HOSPITAL   (France)

^e FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

Epigenetics; Genomic polymorphism; Lung cancer; Never smoker; Pollution epidemiology

Indexed keywords

ARTICLE; ASIAN; BLOOD SAMPLING; CANCER EPIDEMIOLOGY; CANCER RISK; EPIGENETICS; FRANCE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; LUNG CANCER; LUNG CANCER IN NEVER SMOKER; MOLECULAR EPIDEMIOLOGY; QUESTIONNAIRE; RISK FACTOR; SMOKING; TELEPHONE INTERVIEW;

CANCER BRONCHIQUE; EPIGENETICS; ÉPIDÉMIOLOGIE; ÉPIGÉNÉTIQUE; GENOMIC POLYMORPHISM; LUNG CANCER; NEVER SMOKER; NON-FUMEUR; POLLUTION; POLLUTION EPIDEMIOLOGY; POLYMORPHISME;

ADENOCARCINOMA; COHORT STUDIES; EPIDEMIOLOGIC RESEARCH DESIGN; FRANCE; HUMANS; LUNG NEOPLASMS; PATIENT SELECTION; QUESTIONNAIRES; RISK FACTORS; SMOKING; SPECIMEN HANDLING;

EID: 84892597360     PISSN: 07618425     EISSN: 17762588     Source Type: Journal    
DOI: 10.1016/j.rmr.2013.03.006     Document Type: Article

References (35)

1. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007;7:778-90. (Pubitemid 47463669)
2. Ferlay J, Shin H-R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
3. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
4. Thun MJ, Henley SJ, Burns D, et al. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006;98:691-9. (Pubitemid 43832505)
5. Couraud S, Zalcman G, Milleron B, et al. Lung cancer in never smokers-a review. Eur J Cancer 2012;48:1299-311.
6. Kawaguchi T, Takada M, Kubo A, et al. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan. J Thorac Oncol 2010;5:1011-7.
7. Quoix E, Monnet I, Scheid P, et al. Management and outcome of French elderly patients with lung cancer: an IFCT survey. Rev Mal Respir 2010;27:421-30.
8. Clément-Duchêne C, Vignaud JM, Stoufflet A, et al. Characteristics of never smoker lung cancer including environmental and occupational risk factors. Lung Cancer 2010;67:144-50.
9. Lissowska J, Foretova L, Dabek J, et al. Family history and lung cancer risk: international multicentre case-control study in Eastern and Central Europe and meta-analyses. Cancer Causes Control 2010;21:1091-104.
10. Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS ONE 2011;6:e17479.
11. Trédaniel J, Aarab-Terrisse S, Teixeira L, et al. Atmospheric air pollution and lung cancer: epidemiologic data. Rev Mal Respir 2009;26:437-45.
12. Büchner FL, Bueno-de-Mesquita HB, Linseisen J, et al. Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 2010;21:357-71.
13. Yang G, Shu XO, Chow WH, et al. Soy food intake and risk of lung cancer: evidence from the Shanghai Women's Health Study and a meta-analysis. Am J Epidemiol 2012;176:846-55.
14. Schwartz AG, Prysak GM, Bock CH, et al. The molecular epidemiology of lung cancer. Carcinogenesis 2007;28:507-18. (Pubitemid 46523346)
15. Subramanian J, Govindan R. Molecular genetics of lung cancer in people who have never smoked. Lancet Oncol 2008;9:676-82. (Pubitemid 351878053)
16. Riely GJ, Kris MG, Rosenbaum D, et al. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin Cancer Res 2008;14:5731-4.
17. Fukui T, Yatabe Y, Kobayashi Y, et al. Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene. Lung Cancer 2012;77:319-25.
18. Paik PK, Arcila ME, Fara M, et al. Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. J Clin Oncol 2011;29:2046-51.
19. Amos CI, Pinney SM, Li Y, et al. A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers. Cancer Res 2010;70:2359-67.
20. Hsiung CA, Lan Q, Hong YC, et al. The 5p15. 33locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet 2010;6:e1001051.
21. Lo YL, Hsiao CF, Jou YS, et al. Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers. Lung Cancer 2011;72:280-6.
22. Lim WY, Chen Y, Ali SM, et al. Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis 2011;32:522-9.
23. Institut national de veille sanitaire, Institut national du cancer, Réseau Fraņcais des Registres de Cancer FRANCIM, Hospices Civils de Lyon, CepiDC Inserm. Projections de l'incidence et de la mortalité par cancer en France en 2010. [Internet]. 2010 Apr p. 75. Available from: http://www.invs.sante.fr/applications/cancers/projections2010/rapport projections nationales cancer 2010.pdf
24. Foeglé J, Hédelin G, Lebitasy MP, et al. Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997. J Thorac Oncol 2007;2:466-74. (Pubitemid 47171800)
25. Wild P, Gonzalez M, Bourgkard E, et al. Occupational risk factors have to be considered in the definition of high-risk lung cancer populations. Br J Cancer 2012;106:1346-52.
26. Travis W, Brambilla E, Mûller-Hemerlinck H. Pathology and genetics of tumours of of the lung, pleura, thymus and Heart. Lyon: IARC Press; 2004.
27. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisci-plinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85.
28. Groome PA, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694-705. (Pubitemid 47357521)
29. Nowak F, Soria JC, Calvo F. Tumour molecular profiling for deciding therapy-the French initiative. Nat Rev Clin Oncol 2012;9:479-86.
30. Varghese AM, Sima CS, Chaft JE, et al. Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers. J Thorac Oncol 2013;8:123-5.
31. Frades I, Matthiesen R. Overview on techniques in cluster analysis. Methods Mol Biol 2010;593:81-107.
32. Van Rooden SM, Heiser WJ, Kok JN, et al. The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov Disord 2010;25:969-78.
33. Henoch I, Ploner A, Tishelman C. Increasing stringency in symptom cluster research: a methodological exploration of symptom clusters in patients with inoperable lung cancer. Oncol Nurs Forum 2009;36:E282-92.
34. Newcomer SR, Steiner JF, Bayliss EA. Identifying subgroups of complex patients with cluster analysis. Am J Manag Care 2011;17:e324-32.
35. Grivaux M, Locher C, Bombaron P, et al. Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31December 2010. Rev Pneumol Clin 2010;66:375-82.